Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience
ConclusionsIn this single health system experience, women start antiresorptive drugs that are unnecessary in 15 –52%. These results highlight the nonuniformity in guideline recommendations, and this has implications for quality of care, cost-effectiveness, and value-of-care analyses for preventing fractures.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Calcium | Cancer | Cancer & Oncology | DEXA Scan | Health Management | Orthopaedics | Osteoporosis | PET Scan | Vitamin D | Vitamins | Women | Xgeva